what's new
New Approach for Evaluating Highly Variable Drugs Based on EMEA Bioequivalence Guideline 2010. Highly variable drugs or drug products (HVDP) issue is one of frequent asked question raised from many pharmaceutical industries.
welcome!
Equilab International, PT was established in November 2002. Through incessant research and innovation this company dedicated to provides services in Bioavailability/Bioequivalence (BA/BE) study and comprehensive Clinical Trial.
PT Equilab International participated in The ICSE, 25-27 October 2011 in Messe Frankfurt, Germany.